Update: Noziplastischer Schmerz

Die „International Association for the Study of Pain“ (IASP) führte im Jahr 2016 als mechanistische dritte Schmerzkategorie den „Noziplastischen Schmerz“ ein. Die IASP-Definition erklärt Noziplastizität als veränderte Nozizeption in Folge einer Modulation der Reizverarbeitung ohne den Nachweis einer Gewebe- oder Nervenschädigung. Die begriffliche Unschärfe und Breite der Definition sowie ihre unklare Verknüpfung mit neurophysiologischen Mechanismen eröffnen damit potenziell einen weiteren Weg der Stigmatisierung der Patient*innen.

Publication History

Article published online:
08 May 2024

• Literatur

• 1 Edwards RR, Dworkin RH, Turk DC. et al. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain 2016; 157: 1851-1871 DOI: 10.1097/j.pain.0000000000000602.
• 2 International Association for the Study of Pain (IASP). IASP Terminology. IASP PAIN Terms. Last Updated December 14, 2017. Im Internet https://www.iasp-pain.org/resources/terminology/; Stand: 18.02.2024
• 3 Magerl W. Noziplastischer Schmerz. Schmerz.Therapie 2022; 5: 9-17 DOI: 10.1055/a-1708-4241.
• 4 Perl ER. Ideas about pain, a historical view. Nat Rev Neurosci 2007; 8: 71-80 DOI: 10.1038/nrn2042.
• 5 Raja SN, Meyer RA, Campbell JN. Peripheral mechanisms of somatic pain. Anesthesiology. 1988; 68: 571-90
• 6 Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686-688 DOI: 10.1038/306686a0.
• 7 Treede RD, Meyer RA, Raja SN. et al. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992; 38: 397-421 DOI: 10.1016/0301-0082(92)90027-c.
• 8 Randić M, Jiang MC, Cerne R. Long-term potentiation and long-term depression of primary afferent neurotransmission in the rat spinal cord. J Neurosci 1993; 13: 5228-5241 DOI: 10.1523/JNEUROSCI.13-12-05228.1993.
• 9 Ikeda H, Heinke B, Ruscheweyh R. et al. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 2003; 299: 1237-1240 DOI: 10.1126/science.1080659.
• 10 Ji RR, Kohno T, Moore KA. et al. Central sensitization and LTP: do pain and memory share similar mechanisms. Trends Neurosci 2003; 26: 696-705 DOI: 10.1016/j.tins.2003.09.017.
• 11 Klein T, Magerl W, Hopf HC. et al. Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. J Neurosci 2004; 24: 964-971 DOI: 10.1523/JNEUROSCI.1222-03.2004.
• 12 Ziegler EA, Magerl W, Meyer RA. et al. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain 1999; 122: 2245-2257 DOI: 10.1093/brain/122.12.2245.
• 13 Klein T, Magerl W, Treede RD. Perceptual correlate of nociceptive long-term potentiation (LTP) in humans shares the time course of early-LTP. J Neurophysiol 2006; 96: 3551-3555 DOI: 10.1152/jn.00755.2006.
• 14 Lang S, Klein T, Magerl W. et al. Modality-specific sensory changes in humans after the induction of long-term potentiation (LTP) in cutaneous nociceptive pathways. Pain 2007; 128: 254-263 DOI: 10.1016/j.pain.2006.09.026.
• 15 Pfau DB, Klein T, Putzer D. et al. Analysis of hyperalgesia time courses in humans after painful electrical high-frequency stimulation identifies a possible transition from early to late LTP-like pain plasticity. Pain 2011; 152: 1532®1539 DOI: 10.1016/j.pain.2011.02.037.
• 16 Treede RD, Hoheisel U, Wang D. et al. Central sensitization: clinical utility of a physiological concept for the International Statistical Classification of Diseases and Related Health Problems and for nociplastic pain. Pain 2022; 163: S99-S107 DOI: 10.1097/j.pain.0000000000002740.
• 17 Woolf CJ, Bennett GJ, Doherty M. et al. Towards a mechanism-based classification of pain?. Pain 1998; 77: 227-229 DOI: 10.1016/S0304-3959(98)00099-2.
• 18 Vardeh D, Mannion RJ, Woolf CJ. Toward a Mechanism-Based Approach to Pain Diagnosis. J Pain 2016; 17: T50-69 DOI: 10.1016/j.jpain.2016.03.001.
• 19 Baron R, Maier C, Attal N. et al. Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 2017; 158: 261-272 DOI: 10.1097/j.pain.0000000000000753.
• 20 Treede RD, Jensen TS, Campbell JN. et al. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-1635 DOI: 10.1212/01.wnl.0000282763.29778.59.
• 21 Dyck PJ, Dyck PJ, Larson TS. et al. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 2000; 23: 510-517 DOI: 10.2337/diacare.23.4.510.
• 22 Rolke R, Baron R, Maier C. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006; 123: 231-243 DOI: 10.1016/j.pain.2006.01.041.
• 23 Maier C, Baron R, Tölle TR. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010; 150: 439-450 DOI: 10.1016/j.pain.2010.05.002.
• 24 Backonja MM, Attal N, Baron R. et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013; 154: 1807-1819 DOI: 10.1016/j.pain.2013.05.047.
• 25 European Medicines Agencies (EMA) 2016. Guideline on the clinical development of medicinal products intended for the treatment of pain. (EMA/CHMP/970057/2011). Im Internet: https://bit.ly/43bKG8D Stand: 07.03.2024
• 26 Freynhagen R, Rolke R, Baron R. et al. Pseudoradicular and radicular low-back pain – a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain 2008; 135: 65-74 DOI: 10.1016/j.pain.2007.05.004.
• 27 Roussel NA, Nijs J, Meeus M. et al. Central sensitization and altered central pain processing in chronic low back pain: fact or myth. Clin J Pain 2013; 29: 625-638 DOI: 10.1097/AJP.0b013e31826f9a71.
• 28 Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arth Rheum 2008; 37: 339-352 DOI: 10.1016/j.semarthrit.2007.09.003.
• 29 Nijs J, Torres-Cueco R, C van Wilgen P. et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician 2014; 17: 447-457 DOI: 10.36076/ppj.2014/17/447.
• 30 Nijs J, Apeldoorn A, Hallegraeff H. et al. Low back pain: Guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain. Pain Phys 2015; 18: E333-E346
• 31 Pfau DB, Krumova EK, Treede RD. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain 2014; 155: 1002–1015 DOI: 10.1016/j.pain.2014.02.004.
• 32 Iannetti GD, Baumgärtner U, Tracey I. et al. Pinprick-evoked brain potentials: a novel tool to assess central sensitization of nociceptive pathways in humans. J Neurophysiol 2013; 110: 1107-1116 DOI: 10.1152/jn.00774.2012.
• 33 Kosek E, Cohen M, Baron R. et al. Do we need a third mechanistic descriptor for chronic pain states?. Pain 2016; 157: 1382-1386 DOI: 10.1097/j.pain.0000000000000507.
• 34 Walsh DA. Nociplastic pain: helping to explain disconnect between pain and pathology. Pain 2021; 162: 2627-2628 DOI: 10.1097/j.pain.0000000000002323.
• 35 Misery L. Pruriplastic Itch – A Novel Pathogenic Concept in Chronic Pruritus. Front Med 2021; 7: 615118 DOI: 10.3389/fmed.2020.615118.
• 36 Cohen ML. Proposed clinical criteria for nociplastic pain in the musculoskeletal system are flawed. Pain 2022; 163: e606-e607 DOI: 10.1097/j.pain.0000000000002505.
• 37 Cohen M, Quintner J, Weisman A. „Nociplastic Pain“: A Challenge to Nosology and to Nociception. J Pain 2023; 24: 2131-2139 DOI: 10.1016/j.jpain.2023.07.019.
• 38 Aydede M, Shriver A. Recently introduced definition of „nociplastic pain“ by the International Association for the Study of Pain needs better formulation. Pain 2018; 159: 1176-1177 DOI: 10.1097/j.pain.0000000000001184.
• 39 Kosek E, Clauw D, Nijs J. et al. Chronic nociplastic pain affecting the musculoskeletal system: Clinical criteria and grading system. Pain 2021; 162: 2629-2634 DOI: 10.1097/j.pain.0000000000002324.
• 40 Nijs J, Lahousse A, Kapreli E. et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med 2021; 10: 3203 DOI: 10.3390/jcm10153203.
• 41 Hoeijmakers JG, Faber CG, Lauria G. et al. Small-fibre neuropathies – advances in diagnosis, pathophysiology and management. Nat Rev Neurol 2012; 8: 369-379 DOI: 10.1038/nrneurol.2012.97.
• 42 Lauria G, Ziegler D, Malik R. et al. The role of sodium channels in painful diabetic and idiopathic neuropathy. Curr Diab Rep 2014; 14: 538 DOI: 10.1007/s11892-014-0538-5.
• 43 Marchi M, Salvi E, Andelic M. et al. TRPA1 rare variants in chronic neuropathic and nociplastic pain patients. Pain 2023; 164: 2048-2059 DOI: 10.1097/j.pain.0000000000002905.
• 44 Quintner J, Cohen M. The hijacking of „nociplastic“. Painlosophy 2021. Im Internet https://painlosophy.wordpress.com/2021/06/08/the-highjacking-of-nociplastic/; Stand: 18.02.2024
• 45 Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet 2021; 397: 2082-2097 DOI: 10.1016/S0140-6736(21)00393-7.
• 46 Bułdyś K, Górnicki T, Kałka D. et al. What Do We Know about Nociplastic Pain?. Healthcare (Basel) 2023; 11: 1794 DOI: 10.3390/healthcare11121794.
• 47 Hausteiner-Wiehle C, Henningsen P. Nociplastic pain is functional pain. Lancet 2022; 399: 1603-1604 DOI: 10.1016/S0140-6736(21)02500-9.
• 48 Cohen SP, Fitzcharles MA, Häuser W. Nociplastic pain is functional pain – Authors' reply. Lancet 2022; 399: 1604 DOI: 10.1016/S0140-6736(21)02506-X.
• 49 Popkirov S, Enax-Krumova EK, Mainka T. et al. Functional pain disorders – more than nociplastic pain. NeuroRehabilitation 2020; 47: 343-353 DOI: 10.3233/NRE-208007.
• 50 Adler M, Taxer B. Quantitative sensorische Testung im Rahmen neuropathischer Schmerzen und ihre Bedeutung für die Physiotherapie. Schmerz 2022; 36: 437-446 DOI: 10.1007/s00482-021-00576-z..
• 51 Magerl W, Krumova EK, Baron R. et al. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 2010; 151: 598-605 DOI: 10.1016/j.pain.2010.07.026.
• 52 Reimer M, Forstenpointner J, Hartmann A. et al. Sensory bedside testing: a simple stratification approach for sensory phenotyping. Pain Rep 2020; 5: e820 DOI: 10.1097/PR9.0000000000000820.
• 53 Nilges P, Rief W. F45.41 Chronische Schmerzstörung mit somatischen und psychischen Faktoren. Eine Kodierhilfe. Schmerz 2010; 24: 209-212 DOI: 10.1007/s00482-010-0908-0.
• 54 Barke A, Korwisi B, Nilges P. et al. Alles anders?. Chronische Schmerzen sind in der ICD-11 keine psychische Störung mehr! Psychotherapeutenjournal 2023; 22: 4-12
• 55 Fitzcharles MA, Cohen SP, Clauw DJ. et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021; 397: 2098-2110 DOI: 10.1016/S0140-6736(21)00392-5.
• 56 Edwards RR, Almeida DM, Klick B. et al. Duration of sleep contributes to next-day pain report in the general population. Pain 2008; 137: 202-207 DOI: 10.1016/j.pain.2008.01.025.
• 57 Neblett R, Cohen H, Choi Y. et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain 2013; 14: 438-45 DOI: 10.1016/j.jpain.2012.11.012.
• 58 Neblett R, Hartzell MM, Cohen H. et al. Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain 2015; 31: 323-32 DOI: 10.1097/AJP.0000000000000113.
• 59 Adams GR, Gandhi W, Harrison R. et al. Do "central sensitization" questionnaires reflect measures of nociceptive sensitization or psychological constructs? A systematic review and meta-analyses. Pain 2023; 164: 1222-1239 DOI: 10.1097/j.pain.0000000000002830.
• 60 Treede RD, Rief W, Barke A. et al. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International classification of diseases (ICD-11). PAIN 2019; 160: 19-27 DOI: 10.1097/j.pain.0000000000001384.
• 61 Kemp HI, Laycock H, Costello A. et al. Chronic pain in critical care survivors: a narrative review. Br J Anaesth 2019; 123: e372-e384 DOI: 10.1016/j.bja.2019.03.025.
• 62 Chimenti RL, Hall MM, Dilger CP. et al. Local Anesthetic Injection Resolves Movement Pain, Motor Dysfunction, and Pain Catastrophizing in Individuals with Chronic Achilles Tendinopathy: A Nonrandomized Clinical Trial. J Orthop Sports Phys Ther 2020; 50: 334-343 DOI: 10.2519/jospt.2020.9242.
• 63 Baroni A, Fregna G, Lamberti N. et al. Fatigue can influence the development of late-onset pain in post-COVID-19 syndrome: An observational study. Eur J Pain 2023; DOI: 10.1002/ejp.2228.
• 64 Foubert A, Roussel NA, Chantrain VA. et al. The Classification of Suspected Predominant Nociplastic Pain in People with Moderate and Severe Haemophilia: A Secondary Exploratory Study. Biomedicines 2023; 11: 2479 DOI: 10.3390/biomedicines11092479.
• 65 Telli H, Özdemir C. Is nociplastic pain, a new pain category, associated with biochemical, hematological, and inflammatory parameters. Curr Med Res Opin 2024; 11: 1-13 DOI: 10.1080/03007995.2024.2304106.
• 66 Martínez-Lavín M. Centralized nociplastic pain causing fibromyalgia: an emperor with no cloths?. Clin Rheumatol 2022; 41: 3915-3917 DOI: 10.1007/s10067-022-06407-5.
• 67 Xie Y, Thomas L, Barbero M. et al. Heightened pain facilitation rather than impaired pain inhibition distinguishes those with moderate/severe disability in work-related neck pain. Pain 2021; 162: 2225-2236 DOI: 10.1097/j.pain.0000000000002213.
• 68 Elgueta-Cancino E, Sheeran L, Salomoni S. et al. Characterisation of motor cortex organisation in patients with different presentations of persistent low back pain. Eur J Neurosci 2021; 54: 7989-8005 DOI: 10.1111/ejn.15511.
• 69 Larkin TE, Kaplan CM, Schrepf A. et al. Altered network architecture of functional brain communities in chronic nociplastic pain. Neuroimage 2021; 226: 117504 DOI: 10.1016/j.neuroimage.2020.117504.
• 70 Sandström A, Ellerbrock I, Löfgren M. et al. Distinct aberrations in cerebral pain processing differentiating patients with fibromyalgia from patients with rheumatoid arthritis. Pain 2022; 163: 538-547 DOI: 10.1097/j.pain.0000000000002387.
• 71 Alshelh Z, Brusaferri L, Saha A. et al. Neuro-immune signatures in chronic low back pain subtypes. Brain 2022; 145: 1098-1110 DOI: 10.1093/brain/awab336.
• 72 Kratz AL, Whibley D, Alschuler KN. et al. Characterizing chronic pain phenotypes in multiple sclerosis: a nationwide survey study. Pain 2021; 162: 1426-1433 DOI: 10.1097/j.pain.0000000000002136.
• 73 Kuisell C, Ploutz-Snyder R, Williams DA. et al. Adolescents and Young Adults With Sickle Cell Disease: Nociplastic Pain and Pain Catastrophizing as Predictors of Pain Interference and Opioid Consumption. Clin J Pain 2023; 39: 326-333 DOI: 10.1097/AJP.0000000000001119.
• 74 Scott JR, Williams DA, Harte SE. et al. Relationship Between Nociplastic Pain Involvement and Medication Use, Symptom Relief, and Adverse Effects Among People Using Medical Cannabis for Chronic Pain. Clin J Pain 2024; 40: 1-9 DOI: 10.1097/AJP.0000000000001164.
• 75 Kohns DJ, Scott R, Castellanos J. et al. The impact of nociplastic pain features on the response to physical therapy in patients with primary myofascial pain. J Back Musculoskelet Rehabil 2022; 35: 1143-1151 DOI: 10.3233/BMR-210244.
• 76 Joyce E, Carr G, Wang S. et al. Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients. Breast Cancer Res Treat 2023; 197: 397-404 DOI: 10.1007/s10549-022-06806-x.
• 77 Ocay DD, Ross BD, Moscaritolo L. et al. The Psychosocial Characteristics and Somatosensory Function of Children and Adolescents Who Meet the Criteria for Chronic Nociplastic Pain. J Pain Res 2023; 16: 487-500 DOI: 10.2147/JPR.S397829.
• 78 Fitzcharles MA, Petzke F, Tölle TR. et al. Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain. Drugs 2021; 81: 2103-2116 DOI: 10.1007/s40265-021-01602-1.
• 79 Ferro Moura Franco K, Lenoir D. et al. Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: A systematic review with meta-analysis. Eur J Pain 2021; 25: 51-70 DOI: 10.1002/ejp.1666.
• 80 Shraim MA, Massé-Alarie H, Hall LM. et al. Systematic Review and Synthesis of Mechanism-based Classification Systems for Pain Experienced in the Musculoskeletal System. Clin J Pain 2020; 36